| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3198425 | Journal of Allergy and Clinical Immunology | 2012 | 13 Pages |
Abstract
The preclinical characterization indicates that particularly rDer p 2/1S can be used as a safe hypoallergenic molecule for both tolerance and vaccination approaches to treat HDM allergy.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kuan-Wei PhD, Katharina MSc, Wayne R. PhD, Ines PhD, Peter MD, Rudolf MD, Susanne PhD,